uk en
LIFE SCIENCES LAWYERS | UKRAINE & CIS
Menu

LEGAL ALLIANCE, founded in 1995, is today one of the leading Ukrainian law firms specializing in legal support to pharmaceutical companies doing business in Ukraine and CIS countries.

OUR CLIENTS represent the following industries: pharmaceuticals, medical devices, consumer goods, medicine, cosmetics, para-pharmaceuticals, chemistry, biotechnology, agriculture and food products.

LEADING ASSOCIATIONS — AIPM Ukraine, APRaD as well as the EBA Healthcare Committee have chosen Legal Alliance as their legal advisor.

128
The main aspects of the involvement of citizens' vehicles during mobilisation
​Recently, the obligation of citizens to provide their own vehicles to meet the needs of the Armed Forces of Ukraine and other military formations has been actively discussed in the public and media space.
227
New regulation in the field of mobilization: status of the draft law, proposed and adopted amendments
On 30 January 2024, the Verkhovna Rada of Ukraine registered Draft Law No. 10449, which proposes amendments to the legislation on military service, mobilization and military registration, to replace Draft Law No. 10378 of 25 December 2023. ​The 84-page Draft Law​ contains proposals for a number of conceptual changes to ​15 regulations​.
355
Balance on the brink: competitive challenges of the Ukrainian pharmaceutical market
The pharmaceutical market is always in the focus of attention of the Antimonopoly Committee of Ukraine (AMCU) due to its social importance. A number of specific features of this market add additional challenges.
612
Legal 500 EMEA 2024: recognition of the firm in 7 legal practices
According to the results of the recently published international study The Legal 500 Europe, Middle East & Africa 2024 LA Law Firm is recognized among the leading law firms of Ukraine.
414
Pharmaceutical sector 2024: what are the changes and expectations in market regulation?
LA Law Firm held a webinar "Regulatory changes for pharmaceutical sector in 2024. Conclusions and forecasts". During the event, the participants discussed changes in the Health Technology Assessment procedure, regulation of prices for medicines, the Prozorro Market Electronic Catalogue, regulatory plans to change approaches to the circulation of dietary supplements, etc.

If you find out a mistake, please, mark it and select Ctrl+Enter to inform us